Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWCapreomycin is a polypeptide antibiotic originally isolated from S. capreolus.1 It is active against M. tuberculosis (MIC = 10 µg/ml). Capreomycin binds to both the 30S and 50S ribosomal subunits, inhibiting protein synthesis.2 It increases survival and decreases lung necrosis in mice infected with the streptomycin-resistant M. tuberculosis strain H37Rv when administered at doses ranging from 50 to 500 mg/kg.3 Formulations containing capreomycin have been used in the treatment of multidrug-resistant tuberculosis.
WARNING This product is not for human or veterinary use.
1. Antituberculosis drugs: Drug interactions, adverse effects, and use in special situations. Part 2: Second line drugs. J. Bras. Pneumol. 36(5), 641-656 (2010).
2. Binding energies of the drugs capreomycin and streptomycin in complex with tuberculosis bacterial ribosome subunits. Phys. Chem. Chem. Phys. 21(35), 19192-19200 (2019).
3. In vitro and in vivo laboratory studies on the antituberculous activity of capreomycin. Ann. N. Y. Acad. Sci. 135(2), 947-959 (1966).